A Bumex, Bumetanide CEP of the European Pharmacopoeia monograph is often referred to as a Bumex, Bumetanide Certificate of Suitability (COS). The purpose of a Bumex, Bumetanide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bumex, Bumetanide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bumex, Bumetanide to their clients by showing that a Bumex, Bumetanide CEP has been issued for it. The manufacturer submits a Bumex, Bumetanide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bumex, Bumetanide CEP holder for the record. Additionally, the data presented in the Bumex, Bumetanide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bumex, Bumetanide DMF.
A Bumex, Bumetanide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bumex, Bumetanide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bumex, Bumetanide suppliers with CEP (COS) on PharmaCompass.